On December 7, the White House announced “New Actions to Lower Health Care and Prescription Drug Costs by Promoting Competition,” which included “a proposed framework for agencies on the exercise of ...
Douglas Crandell, Agnes Juang, Ph.D. Is one of the four statutory circumstances under 35 U.S.C. § 203(a)[11] met for the march-in rights to be exercised? Contractor or assignee has not taken, or is ...
A group of 51 lawmakers are calling on the National Institutes of Health (NIH) to issue guidance on when "march-in rights" could be used to bypass patents on drugs developed using federal funding. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results